XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,093,800 | -55.2% | 617,500 | -49.5% | 0.70% | -48.3% |
Q2 2023 | $47,100,015 | -28.2% | 1,223,377 | -33.2% | 1.36% | -29.6% |
Q1 2023 | $65,573,507 | -13.4% | 1,832,174 | -4.6% | 1.94% | -9.0% |
Q4 2022 | $75,755,794 | -1.1% | 1,921,273 | -9.5% | 2.13% | -4.4% |
Q3 2022 | $76,624,000 | +18.7% | 2,122,535 | 0.0% | 2.22% | +10.0% |
Q2 2022 | $64,568,000 | -12.4% | 2,122,535 | -12.0% | 2.02% | +36.9% |
Q1 2022 | $73,718,000 | -51.1% | 2,411,447 | -50.0% | 1.48% | +27.1% |
Q4 2021 | $150,668,000 | +387.6% | 4,822,894 | +138.5% | 1.16% | +158.8% |
Q3 2021 | $30,897,000 | -50.6% | 2,022,051 | -39.8% | 0.45% | +10.6% |
Q2 2021 | $62,524,000 | +578.2% | 3,357,946 | +552.0% | 0.41% | +247.0% |
Q1 2021 | $9,219,000 | +304.3% | 515,042 | -28.8% | 0.12% | +1.7% |
Q2 2017 | $2,280,000 | -21.2% | 723,853 | 0.0% | 0.12% | -30.3% |
Q1 2017 | $2,895,000 | -49.2% | 723,853 | -2.2% | 0.16% | -59.3% |
Q4 2016 | $5,700,000 | -7.8% | 740,272 | -3.0% | 0.40% | +1.5% |
Q3 2016 | $6,179,000 | +142.0% | 762,800 | +76.2% | 0.40% | +125.4% |
Q2 2016 | $2,553,000 | +77.5% | 432,800 | +110.3% | 0.18% | +40.5% |
Q1 2016 | $1,438,000 | -13.1% | 205,800 | 0.0% | 0.13% | +3.3% |
Q4 2015 | $1,655,000 | -51.3% | 205,800 | -50.0% | 0.12% | -10.3% |
Q3 2015 | $3,398,000 | +31.0% | 411,600 | +82.9% | 0.14% | -12.8% |
Q2 2015 | $2,594,000 | -31.6% | 225,000 | 0.0% | 0.16% | -47.1% |
Q1 2015 | $3,795,000 | -14.6% | 225,000 | 0.0% | 0.30% | -20.9% |
Q4 2014 | $4,444,000 | – | 225,000 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |